# The Effect of BEPREVE 1.5% on Tear Film Osmolarity and Tear Film Lipid Layer

> **NCT01346371** · PHASE4 · COMPLETED · sponsor: **Minnesota Eye Consultants, P.A.** · enrollment: 40 (actual)

## Conditions studied

- Allergic Conjunctivitis

## Interventions

- **DRUG:** Refresh Tears 0.5% Lubricant Eye Drops
- **DRUG:** Bepreve 1.5% Ophthalmic Solution

## Key facts

- **NCT ID:** NCT01346371
- **Lead sponsor:** Minnesota Eye Consultants, P.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2012-08
- **Final completion:** 2012-09
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2020-03-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01346371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01346371, "The Effect of BEPREVE 1.5% on Tear Film Osmolarity and Tear Film Lipid Layer". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01346371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*